Insulin-mediated oxidative stress and DNA damage in LLC-PK1 pig kidney cell line, female rat primary kidney cells, and male ZDF rat kidneys in vivo

Endocrinology

Volumn 154, Issue 4, 2013, Pages 1434-1443

  Othman, Eman Maher ^a,b   Kreissl, Michael C ^c   Kaiser, Franz R ^c   Arias Loza, Paula Anahi ^a   Stopper, Helga ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Minia University   (Egypt)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MITOCHONDRIAL DNA; NITRATE REDUCTASE (NADH); PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA DAMAGE; ENZYME PHOSPHORYLATION; FEMALE; GLUCOSE BLOOD LEVEL; HYPERINSULINEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; KIDNEY CANCER; KIDNEY CELL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; COMET ASSAY; DNA DAMAGE; FEMALE; HL-60 CELLS; HUMANS; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; LLC-PK1 CELLS; MALE; NEOPLASMS; ONCOGENE PROTEIN V-AKT; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; RATS; REACTIVE OXYGEN SPECIES; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; SWINE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84875869958     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1768     Document Type: Article

References (54)

1. Zamami Y, Takatori S, Hobara N, et al. Hyperinsulinemia induces hypertension associated with neurogenic vascular dysfunction resulting from abnormal perivascular innervations in rat mesenteric resistance arteries. Hypertens Res. 2011; 34(11):1190-1196.
2. Arthur LS, Selvakumar R, Seshadri MS, Seshadri L. Hyperinsulinemia in polycystic ovary disease. J Reprod Med. 1999;44:783-787.
3. Yam D, Fink A, Mashiah A, Ben-Hur E. Hyperinsulinemia in colon, stomach and breast cancer patients. Cancer Lett. 1996;104:129-132.
4. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007;86:s836-s842.
5. Gunter MJ, Hoover DR, Yu H, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2009;101:48-60.
6. Boyd DB. Insulin and cancer. Integr Cancer Ther. 2003;2:315-329.
7. Hsu IR, Kim SP, Kabir M, Bergman RN. Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr. 2007;86:s867-s871.
8. Balkau B, Kahn HS, Courbon D, Eschwege E, Ducimetiere P. Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: the Paris Prospective Study. Diabetes Care. 2001;24:843-849.
9. Giovannucci E. The role of insulin resistance and hyperinsulinemia in cancer causation. Curr Med Chem Immunol Endocr Metab Agents. 2005;5:53-60.
10. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer. 2009;16:1103-1123.
11. Ferrannini E, Cobelli C. The kinetics of insulin in man. II. Role of the liver. Diabetes Metab Rev. 1987;3:365-397.
12. Washio M, Mori M. Risk factors for renal cell cancer in a Japanese population. Clin Med Oncol. 2009;3:71-75.
13. Larsson SC, Wolk A. Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies. Diabetologia. 2011;54: 1013-1018.
14. Habib SL, Prihoda TJ, Luna M, Werner SA. Diabetes and risk of renal cell carcinoma. J Cancer. 2012;3:42-48.
15. Bae YS, Kang SW, Seo MS, et al. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptormediated tyrosine phosphorylation. J Biol Chem. 1997;272:217-221.
16. Bae YS, Sung JY, Kim OS, et al. Platelet-derived growth factorinduced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem. 2000;275:10527-10531.
17. Junn E, Lee KN, Ju HR, et al. Requirement of hydrogen peroxide generation in TGF-β1 signal transduction in human lung fibroblast cells: involvement of hydrogen peroxide and Ca2 in TGF-β1-induced IL-6 expression. J Immunol. 2000;165:2190-2197.
18. Meng TC, Fukada T, Tonks NK. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell. 2002;9: 387-399.
19. Rhee SG, Bae YS, Lee SR, Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000;2000:pe1.
20. Krieger-Brauer HI, Medda PK, Kather H. Insulin-induced activation of NADPH-dependent H2O2 generation in human adipocyte plasma membranes is mediated by Gαi2. J Biol Chem. 1997;272: 10135-10143.
21. Mahadev K, Wu X, Zilbering A, Zhu L, Lawrence JT, Goldstein BJ. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem. 2001;276:48662-48669.
22. Mahadev K, Zilbering A, Zhu L, Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem. 2001;276:21938-21942.
23. Espinosa A, Garcia A, Hartel S, Hidalgo C, Jaimovich E. NADPH oxidase and hydrogen peroxide mediate insulin-induced calcium increase in skeletal muscle cells. J BiolChem. 2009;284:2568-2575.
24. San Jose G, Bidegain J, Robador PA, Diez J, Fortuno A, Zalba G. Insulin-induced NADPH oxidase activation promotes proliferation and matrix metalloproteinase activation in monocytes/macrophages. Free Radic Biol Med. 2009;46:1058-1067.
25. Kwintkiewicz J, Spaczynski RZ, Foyouzi N, Pehlivan T, Duleba AJ. Insulin and oxidative stress modulate proliferation of rat ovarian theca-interstitial cells through diverse signal transduction pathways. Biol Reprod. 2006;74:1034-1040.
26. McCall MR, Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radical Bio Med. 1999;26: 1034-1053.
27. Loft S, Poulsen HE. Cancer risk and oxidativeDNAdamage in man. J Mol Med (Berl). 1996;74:297-312.
28. Kryston TB, Georgiev AB, Pissis P, Georgakilas AG. Role of oxidative stress andDNAdamage in human carcinogenesis. Mutat Res. 2011;711:193-201.
29. Brink A, Schulz B, Kobras K, Lutz WK, Stopper H. Time-dependent effects of sodium arsenite onDNAbreakage and apoptosis observed in the comet assay. Mutat Res. 2006;603:121-128.
30. Burlinson B, Tice RR, Speit G, et al. Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup. Mutat Res. 2007;627:31-35.
31. Hartmann A, Agurell E, Beevers C, et al. Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis. 2003;18:45-51.
32. Tice RR, Agurell E, Anderson D, et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen. 2000;35:206-221.
33. Schmid U, Stopper H, Schweda F, Queisser N, Schupp N. Angiotensin II induces DNA damage in the kidney. Cancer Res. 2008;68: 9239-9246.
34. Queisser N, Oteiza PI, Stopper H, Oli RG, Schupp N. Aldosterone induces oxidative stress, oxidative DNA damage and NF-κB-activation in kidney tubule cells. Mol Carcinog. 2011;50:123-135.
35. Chen S, Synowsky S, Tinti M, Mackintosh C. The capture of phosphoproteins by 14-3-3 proteins mediates actions of insulin. Trends Endocrinol Metab. 2011;22:429-436.
36. Heuson JC, Legros N. Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction. Cancer Res. 1972;32:226-232.
37. Heuson JC, Legros N, Heimann R. Influence of insulin administration on growth of the 7,12-dimethylbenz (a) anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats. Cancer Res 1972;32:233-238.
38. Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys. 2002;397:342-344.
39. Wilcox CS, Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev. 2008;60:418-469.
40. Heumuller S, Wind S, Barbosa-Sicard E, et al. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension. 2008;51:211-217.
41. Garcia-Cazarin ML, Smith JL, Clair DK, Piascik MT. The α1Dadrenergic receptor induces vascular smooth muscle apoptosis via a p53-dependent mechanism. Mol Pharmacol. 2008;74:1000-1007.
42. Li G, Barrett EJ, Wang H, Chai W, Liu Z. Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells. Endocrinology. 2005;146:4690-4696.
43. Saperstein R, Vicario PP, Strout HV, et al. Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells. Biochemistry. 1989;28: 5694-5701.
44. Diaz LE, Chuan YC, Lewitt M, et al. IGF-II regulates metastatic properties of choriocarcinoma cells through the activation of the insulin receptor. Mol Hum Reprod. 2007;13:567-576.
45. Varewijck AJ, Janssen JA. Insulin and its analogues and their affinities for the IGF1 receptor. Endocr Relat Cancer. 2012;19:F63-F75.
46. Riedemann J, Macaulay VM. IGF1R signalling and its inhibition. Endocr Relat Cancer 2006;13(suppl 1):S33-S43.
47. Girnita A, Girnita L, del Prete F, Bartolazzi A, Larsson O, Axelson M. Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth. Cancer Res. 2004;64:236-242.
48. Doghman M, Axelson M, Lalli E. Potent inhibitory effect of the cyclolignan picropodophyllin (PPP) on human adrenocortical carcinoma cells proliferation. Am J Cancer Res. 2011;1:356-361.
49. Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol. 1994;11:95-102.
50. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci. 2003;24:471-478.
51. Milosevic N, Bekhite MM, Sharifpanah F, Ruhe C, Wartenberg M, Sauer H. Redox stimulation of cardiomyogenesis versus inhibition of vasculogenesis upon treatment of mouse embryonic stem cells with thalidomide. Antioxid Redox Signal. 2010;13:1813-1827.
52. Sauer H, Engel S, Milosevic N, Sharifpanah F, Wartenberg M. Activation of AMP-kinase by AICAR induces apoptosis of DU-145 prostate activation of c-Jun N-terminal kinase. Int J Oncol. 2012; 40:501-508.
53. Lee SB, Bae IH, Bae YS, Um HD. Link between mitochondria and NADPH oxidase 1 isozyme for the sustained production of reactive oxygen species and cell death. J Biol Chem. 2006;281:36228-36235.
54. Hamurcu Z, Bayram F, Kahriman G, Donmez-Altuntas H, Baskol G. Micronucleus frequency in lymphocytes and 8-hydroxydeoxyguanosine level in plasma of women with polycystic ovary syndrome. Gynecol Endocrinol. 2010;26:590-595.